Article
Effect of Bile Acid Sequestrants on the Risk of Cardiovascular Events: A Mendelian Randomization Analysis.
Circulation. Cardiovascular genetics - 1 Aug 2015
Ross Stephanie, D'Mello Matthew, Anand Sonia S, Eikelboom John, Stewart Alexandre F R, Samani Nilesh J, Roberts Robert, Paré Guillaume
Abstract excerpt
BACKGROUND: Statins lower low-density lipoprotein cholesterol (LDL-C) and risk of coronary artery disease (CAD), but they may be ineffective or not tolerated. Bile acid sequestrants (BAS) reduce LDL-C, yet their clinical efficacy on CAD remains controversial. METHODS AND RESULTS: We conducted a systematic review and meta-analysis of randomized controlled trials to assess the effect of cholestyramine and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
